Growing adoption of pharmacologic maintenance therapy after allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a survey on behalf of the EBMT acute leukemia working party.

IF 4.5 2区医学 Q1 HEMATOLOGY

Bone Marrow Transplantation Pub Date : 2025-04-15 DOI:10.1038/s41409-025-02576-4

Iman Abou Dalle, Myriam Labopin, Irma Khvedelidze, Frédéric Baron, Eolia Brissot, Gesine Bug, Jordi Esteve, Sebastian Giebel, Norbert-Claude Gorin, Francesco Lanza, Arnon Nagler, Zina Peric, Simona Piemontese, Annalisa Ruggeri, Jaime Sanz, Bipin Savani, Christoph Schmid, Roni Shouval, Alexandros Spyridonidis, Jurjen Versluis, Fabio Ciceri, Ali Bazarbachi, Mohamad Mohty

引用次数: 0

查看原文本刊更多论文

急性髓系白血病异基因造血细胞移植后越来越多地采用药物维持治疗：一项代表EBMT急性白血病工作组的调查。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Bone Marrow Transplantation 医学-免疫学

CiteScore

8.40

自引率

8.30%

发文量

337

审稿时长

6 months

期刊介绍： Bone Marrow Transplantation publishes high quality, peer reviewed original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation. The broad scope of the journal thus encompasses topics such as stem cell biology, e.g., kinetics and cytokine control, transplantation immunology e.g., HLA and matching techniques, translational research, and clinical results of specific transplant protocols. Bone Marrow Transplantation publishes 24 issues a year.